Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Brought to you by

AMAG acquires Cord Blood Registry for $700mm

26 Apr 2021

Executive Summary

AMAG Pharmaceuticals Inc. acquired Cord Blood Registry Inc. (CBR), a private newborn stem cell banking company, for $700mm in cash, or approximately 5.6x CBR's 2014 pro form revenue ($126mm) and 15.6x its EBIDTA ($45mm). AMAG funded the transaction via a concurrent $800mm debt offering.

Deal Industry
  • Pharmaceuticals
  • Services
  • Biotechnology
    • Gene Therapy, Cell Therapy
Deal Status
  • Final
Deal Type
  • Acquisition
    • Acquisition of Private Biotech
    • Full Acquisition
    • Includes Contract
    • Intra-Biotech Deal
    • Payment Includes Cash for Equity

Related Companies

UsernamePublicRestriction

Register

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By